Abstract
Radioembolization with yttrium-90 (90Y) micro- spheres represents an innovative approach that has gained increasing awareness and clinical use over the past 5-10 years. The minimal toxicity of radioembolization and the ability to discharge the patient on an outpatient basis make the therapy an attractive alternative in the treatment of primary and metastatic liver malignancies. Patients are able to resume normal activities shortly following treat- ment, with minimal side effects, in contrast to the post-embolization syndrome often associated with current chemoembolic techniques.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Thera Sphere (2004) TheraSphere Yttrium-90 micro-spheres package insert, MDS Nordion, Kanata, Canada
SIRTeX Medical (2004) SIR-Spheres Yttrium-90 micro-spheres package insert, SIRTeX Medical, Lane Cove, Australia
Flynn WJ (1967) The treatment of pulmonary metastases with microspheres of yttrium 90. Minerva Med 58:4498–500
Greene WM (1963) Embolization of dog prostates with yttrium-90 microspheres. J Urol 90:451–457
Wollner I, Knutsen C, Smith P, Prieskorn D, Chrisp C, Andrews J, Juni J, Warber S, Klevering J, Crudup J, Ensminger W (1988) Effects of hepatic arterial yttrium 90 glass microspheres in dogs. Cancer 61:1336–1344
Wollner IS, Knutsen CA, Ullrich KA, Chrisp CE, Juni JE, Andrews JC, Tuscan MJ, Stetson PL, Ensminger WD (1987) Effects of hepatic arterial yttrium-90 microsphere administration alone and combined with regional bro-modeoxyuridine infusion in dogs. Cancer Res 47:3285–3290
Ariel I (1965) Intra-arterial injection of radioactive microspheres of ceramic in the treatment of malignant tumors. Indications and clinical results. Minerva Med 56:2030–2037
Ariel IM (1965) Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres). Ann Surg 162:267–278
Ariel IM, Flynn W, Pack GT (1967) Current possibilities of radioactive ceramic microspheres labeled with yttrium 90. Minerva Med 58:4496–4498
Ariel IM, Padula G (1973) Irradiation of the spleen by the intra-arterial administration of 90 yttrium microspheres in patients with malignant lymphoma. A preliminary report. Cancer 31:90–96
Simon N, Siffert R, Baron MG, Mitty HA, Rudavsky A (1968) Preoperative irradiation of osteogenic sarcoma with intra-arterially injected yttrium-90 microspheres. Case report. Cancer 21:453–455
Jaffe R, Simon N (1968) Treatment of brain tumors with internally deposited yttrium 90. Neurology 18:309
Pandey U, Bapat KN, Samuel G, Sarma HD, Chaudhari PR, Dhami PS, Kannan R, Venkatesh M (2005) Evaluation of 90Y phosphate particles as a possible radiation synoviorthesis agent. Nucl Med Commun 26:459–463
Sojan S, Bartholomeusz D (2005) Cutaneous radiation necrosis as a complication of yttrium-90 synovectomy. Hell J Nucl Med 8:58–59
Dunn AL, Manco-Johnson M, Busch MT, Balark KL, Abshire TC (2005) Leukemia and P32 radionuclide synovectomy for hémophilie arthropathy. J Thromb Hae-most 3:1541–1542
Chadzopoulos D, Badiavas K (2005) Complications in 90Y radiation synovectomy. Hell J Nucl Med 8:134; author reply 134
Sheppeard H, Aldin A, Ward DJ (1981) Osmic acid versus yttrium-90 in rheumatoid synovitis of the knee. Scand J Rheumatol 10:234–236
Chamberlain MN, Gray BN, Heggie JC, Chmiel RL, Bennett RC (1983) Hepatic métastases-a physiological ap-proach to treatment. Br J Surg 70:596–598
Mantravadi RV, Spigos DG, Tan WS, Felix EL (1982) Intraarterial yttrium 90 in the treatment of hepatic malignancy. Radiology 142:783–786
Mantravadi RV, Spigos DG, Karesh SM, Pavel DG, Grady EG, Capek V (1983) Work in progress: intra-arterial P-32 chromic phosphate for prevention of postoperative liver métastases in high-risk colorectal cancer patients. Radiology 148:555–559
Hafeli UO, Casillas S, Dietz DW, Pauer GJ, Rybicki LA, Conzone SD, Day DE (1999) Hepatic tumor radioemboli-zation in a rat model using radioactive rhenium (186Re/ 188Re) glass microspheres. Int J Radiat Oncol Biol Phys 44:189–199
Nijsen F, Rook D, Brandt C, Meijer R, Dullens H, Zonnenberg B, de Klerk J, van Rijk P, Hennink W, van het Schip F (2001) Targeting of liver tumour in rats by se-lective delivery of holmium-166 loaded microspheres: a biodistribution study. Eur J Nucl Med 28:743–749
Vuorela J, Kauppinen T, Sokka T (2005) Distribution of radiation in synovectomy of the knee with 166Ho-FHMA using image fusion. Cancer Biother Radiopharm 20:333–337
Yan L, Li L, Chen S (1996) Radioembolization with 32P-labelled glass microspheres for advanced hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi 34:526–529
Yan L, Li Z, Li L, Wang L, Lu W, Xie X, Liang Z (2000) The relationship between effects and radiation doses of intra-arterial phosphorus-32 glass microspheres embolization therapy for patients with advanced liver cancer. Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery] 38:837–840
Keng GH, Sundram FX, Yu SW, Somanesan S, Premaraj J, Oon CJ, Kwok R, Htoo MM (2002) Preliminary experience in radionuclide therapy of hepatocellular carcinoma using hepatic intra-arterial radio-conjugates. Ann Acad Med Singapore 31:382–386
Kumar A, Bal C, Srivastava DN, Thulkar SP, Sharma S, Acharya SK, Duttagupta S (2006) Management of multiple intrahepatic recurrences after radiofrequency ablation of hepatocellular carcinoma with rhenium-188-HDD-lipiodol. Eur J Gastroenterol Hepatol 18:219–223
Kumar A, Srivastava DN, Bal C (2006) Management of postsurgical recurrence of hepatocellular carcinoma with rhenium 188-HDD labeled iodized oil. J Vasc Interv Radiol 17:157–161
Yoon CJ, Chung JW, Park JH, Kim YI, Lee KH, Jeong JM, Paeng JC (2004) Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor. J Vasc Interv Radiol 15:1121–1128
Lin WY, Tsai SC, Hsieh JF, Wang SJ (2000) Effects of 90Y-microspheres on liver tumors: comparison of intra-tumoral injection method and intra-arterial injection method. J Nucl Med 41:1892–1897
Yan ZP, Lin G, Zhao HY, Dong YH (1993) Yttrium-90 glass microspheres injected via the portal vein. An ex-perimental study. Acta Radiol 34:395–398
Tian JH, Xu BX, Zhang JM, Dong BW, Liang P, Wang XD (1996) Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J Nucl Med 37:958–963
Hafeli UO, Sweeney SM, Beresford BA, Humm JL, Macklis RM (1995) Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results. Nucl Med Biol 22:147–155
Hafeli UO, Sweeney SM, Beresford BA, Sim EH, Macklis RM (1994) Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracavitary radiotherapy. J Biomed Mater Res 28:901–908
Rudge S, Peterson C, Vessely C, Koda J, Stevens S, Catterall L (2001) Adsorption and desorption of chemo-therapeutic drugs from a magnetically targeted carrier (MTC). J Control Release 74:335–340
Hernandez MC, Knox SJ (2003) Radiobiology of radioim-munotherapy with 90Y ibritumomab tiuxetan (Zevalin). Semin Oncol 30[6 Suppl 17]:6–10
Hernandez MC, Knox SJ (2004) Radiobiology of ra-dioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 59:1274–187
Toegel S, Mien LK, Wadsak W, Eidherr H, Viernstein H, Kluger R, Ettlinger D, Kletter K, Dudczak R, Mitterhauser M (2006) In vitro evaluation of no carrier added, carrier added and cross-complexed [90Y]-EDTMP provides evidence for a novel „foreign carrier theory“. Nucl Med Biol 33:95–99
Araki N, Nagata Y, Fujiwara K, Aoki T, Mitsumori M, Kimura H, Itasaka S, Saitou H, Hiraoka M, Kawashita M, Kokubo T (2001) Evaluation of glass microspheres for intra-arterial radiotherapy in animal kidneys. Int J Radiat Oncol Biol Phys 49:459–463
Becker CD, Rosier H, Biasiutti FD, Baer HU (1995) Congestive hypersplenism: treatment by means of radioemboli-zation of the spleen with Y-90. Radiology 195:183–186
Mulcahy MF, Benson AB 3rd (2005) Bevacizumab in the treatment of colorectal cancer. Expert Opin Biol Ther 5:997–1005
Stathopoulos GP, Rigatos SK, Stathopoulos JG, Xynotroulas JP, Dimou E (2005) Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin. Am J Clin Oncol 28:565–569
Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88:78–85
Van Hazel G, Price D, Bower G, Blanshard KS, Steward WP, Sharma RA (2005) Selective internal radiation therapy (SIRT) plus systemic chemotherapy with FOLFOX4: a phase I dose escalation study. ASCO GI Symposium 2005, Miami, Florida
Van Hazel G, Price D, Bower G, Sharma RA, Blanshard K, Steward WP (2005) Selective internal radiation therapy (SIRT) for liver métastases with concomitant systemic oxaliplatin, 5-fluorouracil and folinic acid: a phase I/II dose escalation study. ASCO GI Symposium 2005, Miami, Florida
Coldwell D, Nutting C, Kennedy AK (2005) Treatment of hepatic métastases from breast cancer with yttrium-90 SIR-Spheres radioembolization. Society of Intervention-al Radiology Annual Meeting 2005, New Orleans, LA
Rubin D, Nutting C, Jones B (2004) Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization. Integr Cancer Ther 3:262–267
Sharma RA, Van Hazel GA, Morgan B, Berry DP, Blanshard K, Price D, Bower G, Shannon JA, Gibbs P, Steward WP (2007) Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25:1099–1106
Herscher LL, Cook JA, Pacelli R, Pass HI, Russo A, Mitchell JB (1999) Principles of chemoradiation: theo-retical and practical considerations. Oncology (Willis-ton Park) 13[10 Suppl 5]:ll–22
Coldwell D, Nutting C, Kennedy AK (2005) Use of yttrium-90 SirSpheres to treat metastatic unresectable neuroendocrine tumors to the liver. World Congress of Gastrointestinal Cancer 2005, Barcelona, Spain
Kennedy A, Coldwell D, Nutting C, Sailer S, Overton C (2005) Hepatic brachytherapy for GI neuroendocrine tumors with Y90 microspheres: long-term USA results. International Congress on Anti-Cancer Treatment 2005, Paris, France
Herba MJ, Thirlwell MP (2002) Radioembolization for hepatic metastases. Semin Oncol 29:152–159
Herba MJ, Illescas FF, Thirlwell MP, Boos GJ, Rosenthall L, Atri M, Bret PM (1988) Hepatic malignancies: improved treatment with intraarterial Y-90. Radiology 169:311–314
Andrews JC, Walker SC, Ackermann RJ, Cotton LA, Ensminger WD, Shapiro B (1994) Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up. J Nucl Med 35:1637–1644
Kim DY, Kwon DS, Salem R, Ma CK, Abouljoud MS (2006) Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation. J Gastrointest Surg 10:413–416
Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, Hunter RD, Nemcek AA Jr, Abecassis MM, Haines KG 3rd, Salem R (2006) Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572–586
Lau WY, Ho SK, Yu SC, Lai EC, Liew CT, Leung TW (2004) Salvage surgery following downstaging of unresectable hepatocellular carcinoma. Ann Surg 240:299–305
Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C (2004) Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60:1552–1563
Voboril R (2005) Blood supply of metastatic liver tumors: an experimental study. Int Surg 90:71–77
Kennedy AS, Dezern W, McNeillie P, England M, Goldner K, Brooks L, Sailer S (2006) Dose selection of resin Y90 microspheres for liver brachytherapy: a single center review. American Brachytherapy Society 2006, Orlando, Florida
Rhee TK, Omary RA, Gates V, Mounajjed T, Larson AC, Barakat O, Sato KT, Mulcahy M, Gordon S, Lewandowski RJ, Salem R (2005) The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma. J Vasc Interv Radiol 16:1085–1091
Kumar A, Srivastava DN, Chau TT, Long HD, Bal C, Chandra P, Chienle T, Hoa NV, Thulkar S, Sharma S, Tarn le H, Xuan TQ, Canh NX, Pant GS, Bandopadhyaya GP (2007) Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment-prospective multicenter clinical trial. Radiology 243:509–519
Avila-Rodriguez MA, Selwyn RG, Hampel JA, Thomadsen BR, Dejesus OT, Converse AK, Nickles RJ (2007) Positron-emitting resin microspheres as surrogates of (90)Y SIR-Spheres: a radiolabeling and stability study. Nucl Med Biol 34:585–590
Deng J, Miller FH, Rhee TK, Sato KT, Mulcahy MF, Kulik LM, Salem R, Omary RA, Larson AC (2006) Diffusionweighted. MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 17:1195–1200
Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK (1997) Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 24:293–298
Keppke AL, Salem R, Reddy D, Huang J, Jin J, Larson AC, Miller FH (2007) Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol 188:768–775
Miller FH, Keppke AL, Reddy D, Huang J, Jin J, Mulcahy MF, Salem R (2007) Response of liver m tastases after treatment with yttrium-90 microspheres: role of size, necrosis, and PET. AJR Am J Roentgenol 188:776–783
Wong CY, Qing F, Savin M, Campbell J, Gates VL, Sherpa KM, Lewandowski RJ, Nagle C, Salem R (2005) Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol 16:1101–1106
Wong CY, Salem R, Qing F, Wong KT, Barker D, Gates V, Lewandowski R, Hill EA, Dworkin HJ, Nagle C (2004) Metabolic response after intraarterial 90Y-glass micro-sphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET. J Nucl Med 45:1892–1897
Wong CY, Salem R, Raman S, Gates VL, Dworkin HJ (2002) Evaluating 90Y-glass microsphere treatment re-sponse of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Eur J Nucl Med Mol Imaging 29:815–820
Lin M, Shon IH, Wilson R, D’Amours SK, Schlaphoff G, Lin P (2007) Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET. Hepa-togastroenterology 54:910–912
Lewandowski RJ, Alii A, Atassi B, Kulik L, Mulcahy MF, Salem R (2006) Retraction of portal vein thrombus following treatment with Y90 TheraSphere: a secondary sign of tumor response. Society of Interventional Radiology 2006, Toronto, Canada
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan. RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430
Bienert M, McCook B, Carr BI, Geller DA, Sheetz M, Amesur N, Avril N (2005) Sequential FDG PET/CT in 90Y microsphere treatment of unresectable colorectal liver métastases. Eur J Nucl Med Mol Imaging 32:723
Bienert M, McCook B, Carr BI, Geller DA, Sheetz M, Tutor C, Amesur N, Avril N (2005) 90Y microsphere treatment of unresectable liver metastases: changes in 18F-FDG uptake and tumour size on PET/CT. Eur J Nucl Med Mol Imaging 32:778–787
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
Salem R, Lewandowski R, Roberts C, Goin J, Thurston K, Abouljoud M, Courtney A (2004) Use of yttrium-90 glass microspheres (TheraSphere) for the treatment of unresectable hepatocellular carcinoma in patients with portal vein thrombosis. J Vasc Interv Radiol 15:335–345
Kim W, Clark TW, Baum RA, Soulen MC (2001) Risk factors for liver abscess formation after hepatic chemoem-bolization. J Vasc Interv Radiol 12:965–968
Thomas KT, Bream PR Jr, Berlin J, Meranze SG, Wright JK, Chari RS (2004) Use of percutaneous drainage to treat hepatic abscess after radiofrequency ablation of metastatic pancreatic adenocarcinoma. Am Surg 70:496–499
Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H (2002) Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 13:1163–1166
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Salem, R., Ibrahim, S., Atassi, B., Lewandowski, R.J. (2008). Future Directions in Radioembolization. In: Bilbao, J.I., Reiser, M.F. (eds) Liver Radioembolization with 90Y Microspheres. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-35423-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-540-35423-9_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-35421-5
Online ISBN: 978-3-540-35423-9
eBook Packages: MedicineMedicine (R0)